Woleai-gugu

Calophyllum inophyllum leaf and seed extracts contain neoflavonoids—particularly inophyllums A–E and P, calophyllolide, and calanolides A and B—alongside abundant phenolics and flavonoids that drive antioxidant, antimicrobial, and anti-inflammatory activity by scavenging reactive oxygen species and modulating ROS-related gene pathways. Leaf methanolic extracts demonstrate a total phenolic content of up to 289.12 mg GAE/g and a DPPH radical-scavenging IC₅₀ as low as 0.054 µg/mL, while antibacterial activity against Staphylococcus aureus produces zones of inhibition averaging 17.96 mm, supporting its traditional Micronesian application as a wound-healing and anti-infective agent.

Origin & History

Calophyllum inophyllum is a large tropical evergreen tree native to coastal regions of the Indo-Pacific, ranging from East Africa and the Indian subcontinent through Southeast Asia to the Pacific Islands, including Micronesia, Fiji, French Polynesia, and New Caledonia. It thrives in sandy, well-drained coastal soils and is frequently found in littoral forests near beaches and lagoons, tolerating high salinity and periodic flooding. In the Federated States of Micronesia, it is known locally as 'Woleai-gugu' on the Woleai atoll and has been cultivated and harvested for generations as part of indigenous botanical medicine traditions.

Historical & Cultural Context

Calophyllum inophyllum occupies a prominent place in the ethnobotanical traditions of Pacific Island societies spanning thousands of years; in Micronesia, specifically on the Woleai atoll of the Federated States of Micronesia, the plant is called 'gugu' and its leaf juice is a recognized remedy for open wound care and the prevention or management of tetanus, a use documented in FSM ethnobotanical surveys. In Polynesia and Melanesia—including Fiji, French Polynesia, and New Caledonia—the seed oil (tamanu oil) is a cornerstone of indigenous healing practice, applied to burns, skin ulcers, leprosy-related lesions, rheumatism, and postpartum recovery, with the oil's preparation by sun-drying seeds followed by cold-pressing representing a technology passed through generations of Pacific healers. The tree holds spiritual and practical significance as a shade and windbreak tree in coastal village landscapes, and its resin oil was historically traded between island groups as a valued medicinal commodity, reflecting its cross-cultural recognition across the Indo-Pacific. Historical European botanical accounts from the 18th and 19th centuries, including observations by naturalists accompanying Pacific voyages, documented indigenous use of tamanu oil, contributing to its eventual adoption in French colonial pharmacy and its later resurgence as a cosmeceutical ingredient in the 20th century.

Health Benefits

- **Wound Healing and Antiseptic Action**: Leaf juice has been applied topically in Micronesian (FSM) tradition to treat wounds and prevent tetanus; phenolic compounds and neoflavonoids in the extract create an antimicrobial microenvironment that inhibits pathogens such as Staphylococcus aureus (zone of inhibition 17.96 mm) and Bacillus cereus (MIC <0.098 mg/mL in 11 of 15 tested extracts).
- **Antioxidant Protection**: Methanolic bark extracts exhibit exceptional DPPH radical-scavenging capacity with an IC₅₀ of 0.004 mg/mL, driven by high total phenolic and flavonoid contents; leaf extracts optimized at 80% methanol/30°C/48 h yield up to 410.4 mg QE/g total flavonoid content, reflecting potent free-radical neutralization.
- **Anti-Cancer Cell Proliferation Inhibition**: In vitro studies on patient-derived breast and lung cancer cell lines show that C. inophyllum extracts reduce intracellular ROS, suppressing cancer cell proliferation, migration, and invasion at 72 hours, with selective cytotoxicity against malignant cells and no cytotoxicity to normal cells observed at 24 hours.
- **Anti-Inflammatory Effects**: Calophyllolide, a neoflavonoid abundant in seed resin oil, inhibits inflammatory pathways; combined with phenolics and flavonoids in bark and leaf fractions, extracts suppress inflammation-associated molecular signaling, supporting traditional use for swelling, skin conditions, and rheumatic complaints across Pacific Island communities.
- **Antimicrobial and Anti-HIV Activity**: Inophyllum C and calanolides A and B—concentrated in seed resin oil and leaves—demonstrate activity against HIV reverse transcriptase and multiple bacterial strains; geographic chemotype variation means French Polynesian material is richer in tamanolide E1/E2 and calanolide Gut 70, while Fijian material predominates in inophyllum C, conferring regionally distinct antimicrobial spectra.
- **Skin Repair via Tamanu Oil**: Cold-pressed seed resin oil (tamanu oil) has a long ethnobotanical record in Fiji, New Caledonia, and French Polynesia for promoting cicatrization (scar healing), treating skin infections, and relieving burns; the oil's neoflavonoid and calophyllolide content is credited with stimulating skin cell regeneration, though controlled clinical trials confirming this mechanism in humans remain absent.
- **Neuroprotective and BBB-Penetrant Bioactive Compounds**: In silico ADME analysis of key compounds—including eugenol and caryophyllene oxide—predicts high gastrointestinal absorption, blood-brain barrier permeability, and Lipinski compliance, suggesting theoretical neuroprotective potential and good oral bioavailability for further pharmacological investigation.

How It Works

Phenolic compounds and flavonoids in Calophyllum inophyllum extracts scavenge reactive oxygen species (ROS) through hydrogen atom transfer and single electron transfer mechanisms, directly neutralizing DPPH and ABTS radicals (DPPH IC₅₀ as low as 0.004 mg/mL for methanolic bark extract), while simultaneously downregulating intracellular ROS-related gene expression pathways implicated in cancer cell proliferation, migration, and invasion. Neoflavonoids—specifically inophyllums B, C, and E—and calanolides A and B inhibit HIV-1 reverse transcriptase through non-nucleoside binding at the reverse transcriptase active site, while inophyllum C additionally targets bacterial membrane integrity and metabolic enzymes in Gram-positive organisms. Calophyllolide exerts anti-inflammatory effects by modulating prostaglandin synthesis pathways and suppressing pro-inflammatory cytokine cascades, an action complemented by alkaloid and tannin fractions (alkaloids 11.51%, tannins 7.68% of methanol-soluble leaf material) that further inhibit microbial enzymatic activity and provide astringent wound-surface protection. Saponins enriched in hexane bark fractions contribute to surfactant-mediated disruption of microbial cell membranes, synergizing with phenolic bacteriostatic action to broaden the antimicrobial spectrum observed in multi-extract MIC assays.

Scientific Research

The current body of evidence for Calophyllum inophyllum consists entirely of in vitro cell culture experiments and in silico computational analyses, with no published human clinical trials reporting sample sizes, effect sizes, or controlled outcomes as of the available literature. In vitro studies demonstrate antiproliferative activity against patient-derived breast and lung cancer cell lines at 72 hours of exposure, with selective cytotoxicity compared to normal cells, and antibacterial performance measured by MIC (<0.098 mg/mL against Bacillus cereus) and agar diffusion (17.96 mm zone against Staphylococcus aureus). Phytochemical optimization studies have quantified extraction-condition-dependent yields—up to 289.12 mg GAE/g total phenolics and 410.4 mg QE/g total flavonoids under 80% methanol at 30°C for 48 hours—providing reproducible benchmarks for standardization but not translating to human dose-response relationships. The evidence base, while mechanistically plausible and internally consistent across multiple research groups examining different geographic chemotypes, must be characterized as preliminary and preclinical; large-animal toxicology studies and Phase I human trials are required before any therapeutic claims can be substantiated.

Clinical Summary

No human clinical trials have been conducted on Woleai-gugu (Calophyllum inophyllum) leaf juice, tamanu oil, or standardized extracts for any indication, including the traditional Micronesian uses of wound healing and tetanus prophylaxis. The entirety of mechanistic evidence derives from in vitro cell-based assays (patient-derived cancer cell lines, bacterial culture MIC/zone-of-inhibition methods) and in silico ADME/drug-likeness computational modeling, neither of which constitutes clinical evidence of efficacy or safety in humans. While the preclinical data are promising—particularly regarding selective anticancer cytotoxicity, potent antioxidant activity, and broad-spectrum antimicrobial action—effect sizes and confidence intervals from human trials are entirely absent, precluding any evidence-based dosing recommendations. Overall confidence in clinical utility is low due to this evidence gap, and the ingredient should be regarded as a candidate for, rather than the subject of, future Phase I/II trial investigation.

Nutritional Profile

Calophyllum inophyllum is not consumed as a dietary food source and does not contribute macronutrient or conventional micronutrient value to human nutrition; its pharmacological interest lies entirely in its secondary metabolite phytochemical composition. Leaf fractions (methanol-soluble) contain alkaloids (~11.51%), tannins (~7.68%), polyphenols (~2.53%), and triterpenoids (~2.48%) by gravimetric fraction analysis. Leaf extracts optimized under 80% methanol conditions yield total phenolic content (TPC) of up to 289.12 mg gallic acid equivalents (GAE)/g dried residue and total flavonoid content (TFC) of up to 410.4 mg quercetin equivalents (QE)/g, both among the higher values reported for tropical medicinal plants. Seed resin oil contains concentrated neoflavonoids—inophyllums A, B, C, D, E, P; calophyllolide; calanolides A, B, D, Gut 70; and tamanolides D and P—at levels that vary significantly by geographic origin (e.g., higher tamanolide E1/E2 in French Polynesia; higher inophyllum C in Fiji). In silico ADME modeling for representative compounds (eugenol, caryophyllene oxide) predicts high gastrointestinal absorption and favorable Lipinski compliance, but experimental human bioavailability data are absent.

Preparation & Dosage

- **Tamanu Oil (Cold-Pressed Seed Resin)**: Applied topically to wounds, skin infections, and scars; no standardized dose established; traditional application involves direct skin contact with undiluted or carrier-blended oil, typically 2–5 drops per application site.
- **Leaf Juice (Fresh Leaf Expression)**: Traditional Micronesian (FSM/Woleai) preparation involves crushing fresh leaves and applying expressed juice directly to wounds or affected skin; frequency and volume are empirical and unstandardized.
- **Methanolic Leaf Extract (Research Grade)**: Optimized at 80% methanol, 30°C, 48 hours extraction; used at 10 mg/mL in in vitro studies; no human equivalent dose established.
- **Methanolic Bark Extract**: Prepared by solvent maceration; high phenolic/flavonoid yield correlates with antioxidant potency (DPPH IC₅₀ 0.004 mg/mL); no human dose defined.
- **Hexane Bark Extract**: Rich in saponins; used as a research fraction for antimicrobial assays; not formulated for human supplementation.
- **Standardization Note**: No commercial standardization to specific neoflavonoid (e.g., calophyllolide, inophyllum B/C) content percentages has been formally established; geographic chemotype variation significantly affects compound profiles and should be considered in any future standardization effort.
- **Timing and Route**: All traditional use is topical; oral administration has not been assessed in clinical settings and cannot be recommended based on current evidence.

Synergy & Pairings

Tamanu oil (Calophyllum inophyllum seed resin) is traditionally combined with coconut oil (Cocos nucifera) as a carrier in Pacific Island wound and skin preparations, where medium-chain fatty acids in coconut oil may enhance dermal penetration of neoflavonoids and calophyllolide, potentially amplifying local anti-inflammatory and antimicrobial effects at the wound surface. The high tannin content of C. inophyllum leaf extracts may act synergistically with flavonoid-rich plants such as noni (Morinda citrifolia), also used in Micronesian traditional medicine, through complementary astringent and antioxidant mechanisms that collectively reduce microbial burden and oxidative tissue damage in wound healing. In research contexts, pairing C. inophyllum extracts with vitamin C (ascorbic acid) has theoretical synergy for ROS suppression, as ascorbate recycles oxidized flavonoid radicals back to their active antioxidant form, though this combination has not been experimentally tested for this specific botanical.

Safety & Interactions

Preclinical in vitro data indicate selective cytotoxicity against cancer cell lines with no cytotoxicity to normal cells at 24-hour exposures, suggesting a favorable initial safety window at concentrations studied (around 10 mg/mL in research settings); however, no formal toxicology studies in animals or humans have been published, and maximum safe doses for any route of administration remain undefined. No drug interaction data exist in the human clinical literature; the in silico prediction of minimal CYP450 inhibition for key compounds (eugenol, caryophyllene oxide) is theoretically reassuring but has not been experimentally validated in human hepatic systems, and the presence of multiple bioactive neoflavonoids with unknown CYP450 profiles warrants caution when co-administering anticoagulants, antiretrovirals, or narrow-therapeutic-index drugs. Contraindications are not formally established; topical tamanu oil has anecdotal reports of contact dermatitis in sensitive individuals, and persons with nut or tree resin allergies should exercise particular caution given the seed-oil preparation method. Use during pregnancy and lactation is not supported by any safety data and cannot be recommended; traditional topical use is generally considered low-risk, but ingestion of extracts or oils should be avoided until human safety data are available.